SCHEMBL6163581

SCHEMBL6163581

N#CCCn1nc(-c2cnc3ccccc3n2)c2c1CCC2=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 12/20 0.36
HIF1A Q16665 4/20 0.36
TSHR P16473 4/20 0.36
HSD17B10 Q99714 10/20 0.36
CYP3A4 P08684 3/20 0.36
GLA P06280 3/20 0.36
CYP2C19 P33261 3/20 0.35
MEN1 O00255 5/20 0.35
KMT2A Q03164 5/20 0.35
MAPT P10636 1/20 0.35
ALDH1A1 P00352 8/20 0.34
CASP1 P29466 7/20 0.34
CASP7 P55210 7/20 0.34
HPGD P15428 4/20 0.34
CYP2C9 P11712 3/20 0.34
USP2 O75604 4/20 0.34
CYP2D6 P10635 3/20 0.34
JAK2 O60674 1/20 0.34
JAK3 P52333 1/20 0.34
MAPK1 P28482 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164630 0.86 HTT (0.41) CYP1A2HSD17B10MEN1KMT2AMAPT
SCHEMBL6165983 0.76 ATM (0.44) CYP1A2TSHRGLAKMT2AMAPT
SCHEMBL6165490 0.74 LMNA (0.49) CYP1A2HIF1ATSHRHSD17B10CYP3A4
SCHEMBL6167036 0.74 RIPK3 (0.39) KMT2AMAPTALDH1A1HPGD
SCHEMBL6166254 0.73 ALDH1A1 (0.38) HIF1ATSHRHSD17B10MEN1KMT2A
SCHEMBL6164086 0.73 ALDH1A1 (0.36) CYP1A2HSD17B10CYP3A4GLAMEN1
SCHEMBL6167558 0.71 BRD4 (0.31)
SCHEMBL6165037 0.71 MAOB (0.42) CYP1A2HIF1ATSHRHSD17B10CYP3A4
SCHEMBL6164485 0.70 MAOB (0.47) CYP1A2HIF1ATSHR
SCHEMBL6166453 0.70 ALDH1A1 (0.39) CYP1A2HIF1ATSHRHSD17B10CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed